comprehensive -WSS

comprehensive

author：entertainment 2025-09-30 21:57:25 - browse：58

Balance innovation — Medicare laid out in the greatest detail yet how it will choose which drug prices it will negotiate in its brand-new program, and how it will figure out what the government’s opening offer will be. Adobe

WASHINGTON — Medicare laid out Wednesday in the greatest detail yet how it will choose which drug prices it will negotiate in its brand-new program, and how it will figure out what the government’s opening offer will be.

Democrats outlined some parts of the process in the Inflation Reduction Act that passed Congress last August, but the details of how drugs will be selected and what factors will be considered have been vague until now. Though the actual negotiated prices won’t take effect for years, Medicare officials must announce the first 10 drugs they’ll negotiate over by Sept. 1.

The guidance clarifies that the agency will choose the 50 pharmacy drugs that cost Medicare the most money, based on gross expenditures. If drugs have the same cost to the program, then the one that has been approved longer will be ranked higher.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Do masks work? RCTs can't tell us

WSS

Results on Novartis prostate cancer therapy could expand its use

Do masks work? RCTs can't tell us

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

3 hurdles to bringing medical devices to the U.S. market

Do masks work? RCTs can't tell us

Why drug prescriptions should include diagnoses

hotspot

comprehensive

knowledge

After affirmative action ruling, medical educators look to 'holistic review'

Paxlovid study fails to answer questions over benefit for broader groups

Medical leaders decry Supreme Court decision on affirmative action

What is the Wagner Group? The 'brutal' Russian military unit in Ukraine

Medical records are filled with copy

The battle over the Brookhaven Landfill on Long Island

Dobbs anniversary: the lost opportunity of abortion as health care

Roche drug slashes death risk in early

As demand for Covid shots wanes, Moderna seeks its next success

Roche drug slashes death risk in early

explore

Roche drug slashes death risk in early

Do masks work? RCTs can't tell us

FDA clears Verve to begin U.S. study of gene

J&J lung cancer data amount to new salvo against AstraZeneca

J&J lung cancer data amount to new salvo against AstraZeneca

Ask STAT: What do you want to know about ChatGPT in medicine?

knowledge

leisure time

focus

knowledge